Please Wait...

Lori Jones

Main profile

Lori Jones
Marketing Manager, Global Clinical Research

Lori executes and manages the marketing directives for Bioclinica's Global Clinical Research business segment. In her role, she works closely with product and sales teams to identify key strategies and initiatives, develops and manages marketing plans, and ensures consistent messaging across brands.

Lori identifies opportunities to advance the marketing message of Global Clinical Research through advertising, events, public relations, social media, newsletters, blogs, webinars, collateral, white papers, sales presentations, and the like.

With a strong background in pharmaceutical marketing, Lori is able to effectively translate her passion for strategy, planning, organization and communications to the clinical trial industry, especially as it relates to patient recruitment, investigator site relations and Phase IV clinical research.

Blogs

Investments in post-approval research are rising steadily year on year. Chances are, post-approval research represents a substantial part of your annual budget. But how much of that money is being wasted by conducting post-approval studies in an inappropriate and inefficient manner?

Bioclinica's extensive Research Network of full-service clinical study sites – already located in Asia, Europe, and Latin America – achieved a global status with the recent acquisition of Compass Research.

Many people don't understand what a clinical trial is or how one is conducted. This can make it hard to recruit and screen the hundreds and often thousands of patients necessary to find qualified individuals to participate in a given study.

Patient engagement is an ongoing challenge when conducting clinical trials. A recent article published in CenterWatch Weekly noted, "Experts point to problems with awareness, understanding, and trust among potential trial participants as well as providers that persists today.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

RT @Xtalks: Removing Risk from #ClinicalTrial Management System (CTMS) Implementations @bioclinica https://t.co/EfuSVMSL13
bioclinica (5 hours ago)
Our Research Dev. Director Marieke Cajal in a poster presentation at #CNS Summit showed, "How to Scale up Recruitme… https://t.co/ySQpGIjvt9
bioclinica (5 hours ago)
Great advice on imaging in #clinicaltrials! https://t.co/adsP8h99Ic
bioclinica (3 days ago)
https://t.co/UZQTot9ovJ
bioclinica (3 days ago)
RT @Xtalks: When is Central Imaging Needed in #ClinicalTrials? @bioclinica https://t.co/fYGvqU46TI
bioclinica (3 days ago)
RT @phillytechnews: 11/7: BioClinica, USA Technologies buy California firms ; First Round names female general partner https://t.co/MAvm6…
bioclinica (3 days ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices